You need to upgrade your Flash Player
price divergence news
1. 64.81 ↘3% Jun 17:
6. 63.29 ↘8% Dec 4:
Company and People Notes: Lilly Completes Acquisiti…
9. 64.00 ↘9% Nov 20:
Sanofi settles US patent dispute with Teva and Barr… (+8 more)
18. 63.00 ↗7% Oct 20:
Barr Revises Timing of Its Earnings Conference Call… (+4 more)
20. 58.46 ↘9% Oct 15:
US court upholds Bayer, Barr deal over Cipro (+3 more)
21. 62.86 ↗15% Oct 13:
26. 65.30 ↗8% Sep 30:
27. 62.13 ↘10% Sep 29:
29. 65.44 ↘7% Sep 15:
40. 63.43 ↗12% Jul 18:
Movers: Citigroup, Google, Barr Labs, Microsoft, Me… (+7 more)
41. 57.17 ↗17% Jul 17:
Teva Pharmaceutical Industries Ltd. Shares Fall On …

Peer Index? Allocation

add BRL to portfolio
Barr Pharmaceuticals, Inc. (Barr) is a holding company. Through its subsidiaries, the Company operates as a global specialty pharmaceutical company with operations in more than 30 countries. Market Cap: $7.00B www.barrlabs.com